Zurcher Kantonalbank Zurich Cantonalbank Has $4.18 Million Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Zurcher Kantonalbank Zurich Cantonalbank decreased its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 18.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,394 shares of the company's stock after selling 13,591 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Henry Schein were worth $4,179,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of HSIC. Principal Financial Group Inc. increased its position in shares of Henry Schein by 2.1% during the 3rd quarter. Principal Financial Group Inc. now owns 145,835 shares of the company's stock worth $10,631,000 after purchasing an additional 3,037 shares during the last quarter. Huntington National Bank increased its holdings in Henry Schein by 16.8% during the third quarter. Huntington National Bank now owns 1,515 shares of the company's stock worth $110,000 after buying an additional 218 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. bought a new stake in Henry Schein during the third quarter worth $301,000. CIBC Asset Management Inc lifted its stake in Henry Schein by 7.0% in the third quarter. CIBC Asset Management Inc now owns 17,680 shares of the company's stock valued at $1,289,000 after acquiring an additional 1,162 shares during the last quarter. Finally, Simplify Asset Management Inc. grew its position in shares of Henry Schein by 61.6% in the 3rd quarter. Simplify Asset Management Inc. now owns 5,972 shares of the company's stock valued at $435,000 after acquiring an additional 2,277 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.

Remove Ads

Henry Schein Stock Performance

Shares of HSIC traded up $0.20 during mid-day trading on Tuesday, hitting $72.00. 832,415 shares of the company's stock were exchanged, compared to its average volume of 1,502,078. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a market cap of $8.94 billion, a price-to-earnings ratio of 29.63, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. The stock's 50-day simple moving average is $74.84 and its 200-day simple moving average is $72.62. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein's revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.66 earnings per share. On average, equities research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on HSIC shares. Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and raised their target price for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Jefferies Financial Group raised their price objective on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research report on Thursday, January 23rd. Wells Fargo & Company started coverage on Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 target price on the stock. UBS Group reduced their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. Finally, Mizuho started coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a "neutral" rating and a $75.00 target price for the company. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.